Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-03

Clinical Trial Update: Nortriptyline for the Treatment of Functional Dyspepsia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nortriptyline for functional dyspepsia was terminated, with no results provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nortriptyline (nortriptyline)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Functional Dyspepsia | Phase 3 | Status: TERMINATED